ID29858A - Uji diagnostik tuberkulosis - Google Patents

Uji diagnostik tuberkulosis

Info

Publication number
ID29858A
ID29858A IDW00200100974A ID20010974A ID29858A ID 29858 A ID29858 A ID 29858A ID W00200100974 A IDW00200100974 A ID W00200100974A ID 20010974 A ID20010974 A ID 20010974A ID 29858 A ID29858 A ID 29858A
Authority
ID
Indonesia
Prior art keywords
peptides
diagnostic test
cells
tuberculosis diagnostic
analogues
Prior art date
Application number
IDW00200100974A
Other languages
English (en)
Inventor
Ajit Lalvani
Ansar A Pathan
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29858(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9824213.4A external-priority patent/GB9824213D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Publication of ID29858A publication Critical patent/ID29858A/id

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW00200100974A 1998-11-04 1999-11-03 Uji diagnostik tuberkulosis ID29858A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10700498P 1998-11-04 1998-11-04
GBGB9824213.4A GB9824213D0 (en) 1998-11-04 1998-11-04 Diagnostic test

Publications (1)

Publication Number Publication Date
ID29858A true ID29858A (id) 2001-10-18

Family

ID=26314614

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100974A ID29858A (id) 1998-11-04 1999-11-03 Uji diagnostik tuberkulosis

Country Status (14)

Country Link
US (5) US7632646B1 (id)
EP (1) EP1144447B1 (id)
JP (1) JP4633931B2 (id)
CN (1) CN1350546A (id)
AT (1) ATE445638T1 (id)
AU (1) AU6480999A (id)
BR (1) BR9915055A (id)
CA (1) CA2348475A1 (id)
DE (1) DE69941545D1 (id)
DK (1) DK1144447T3 (id)
ES (1) ES2333073T3 (id)
ID (1) ID29858A (id)
MX (1) MXPA01004469A (id)
WO (1) WO2000026248A2 (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
CA2348475A1 (en) 1998-11-04 2000-05-11 Isis Innovation Limited Tuberculosis diagnostic test
EP1390755B1 (en) 2001-01-08 2012-10-10 Isis Innovation Limited Assay to determine efficacy of treatment for mycobacterial infection
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
US7888037B2 (en) * 2004-02-19 2011-02-15 Department Of Biotechnology Diagnostic kit for detecting pulmonary and extra pulmonary tuberculosis
CN1305900C (zh) * 2004-03-16 2007-03-21 中国药品生物制品检定所 Esat－6蛋白在诊断结核病中的用途
GB0406271D0 (en) 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
CA2616766A1 (en) * 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
CN101294964B (zh) * 2007-11-27 2012-06-27 复旦大学附属华山医院 一种检测活动性结核病和结核潜伏感染的试剂和方法
CN102297968B (zh) * 2010-06-28 2013-10-30 程小星 辅助诊断结核病的试剂盒
ITRM20100411A1 (it) * 2010-07-23 2012-01-24 Massimo Amicosante Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino.
CN101987872B (zh) * 2010-10-12 2011-11-09 浙江大学 抗结核杆菌esat-6单克隆抗体tbea8及应用
CN101985473B (zh) * 2010-10-12 2011-11-09 浙江大学 抗结核杆菌esat-6单克隆抗体tbef3及应用
IT1403092B1 (it) 2010-12-01 2013-10-04 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio della mucormicosi.
CN102305855A (zh) * 2011-05-19 2012-01-04 中山大学 体外检测结核分枝杆菌感染的试剂和方法
MX347154B (es) 2012-02-24 2017-02-21 Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
RU2571713C2 (ru) * 2014-05-12 2015-12-20 Федеральное Государственное Бюджетное Учреждение "Новосибирский научно-исследовательский институт туберкулеза" Минздрава России (ФГБУ "ННИИТ" Минздрава России) Способ диагностики латентного туберкулеза внелегочных локализаций
CN105954521B (zh) * 2016-07-08 2017-04-12 广州华弘生物科技有限公司 一种结核分枝杆菌感染诊断试剂盒
US10245320B2 (en) 2016-09-30 2019-04-02 Enzo Biochem, Inc. Immunomodulatory pharmaceutical compositions and methods of use thereof
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
ES2933132T3 (es) 2017-05-05 2023-02-01 Biomerieux Sa Procedimiento para detectar una respuesta celular inmune
EP3399312A1 (fr) * 2017-05-05 2018-11-07 Biomérieux Procédé de détection d'une réponse cellulaire immune
WO2019018607A1 (en) 2017-07-20 2019-01-24 Enzo Biochem, Inc. IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF
WO2022076428A1 (en) 2020-10-06 2022-04-14 Cepheid Methods of diagnosing tuberculosis and differentiating between active and latent tuberculosis

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
US6991797B2 (en) * 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6641814B1 (en) * 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5775870A (en) * 1995-08-03 1998-07-07 Hogan; Sherman David Vehicle side tilting apparatus
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) * 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
CA2684425A1 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6087163A (en) * 1997-02-06 2000-07-11 The Public Health Research Institute Of The City Of New York, Inc. Mycobacterium tuberculosis specific proteins and genes, mixtures of anitgens and uses thereof
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
US6245331B1 (en) * 1997-01-02 2001-06-12 New York Univ. Medical Center Early detection of mycobacterial disease
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6982085B2 (en) * 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) * 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
EP0902086A1 (en) * 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
WO1999045119A2 (en) * 1998-03-06 1999-09-10 Statens Serum Institut Production of mycobacterial polypeptides by lactic acid bacteria
AU753995B2 (en) * 1998-04-07 2002-10-31 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US20030044431A1 (en) * 1998-06-19 2003-03-06 Gerhardt Schurig Over-expressing homologous antigen vaccine and a method of making the same
CA2348475A1 (en) * 1998-11-04 2000-05-11 Isis Innovation Limited Tuberculosis diagnostic test
US20020131976A1 (en) * 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
US6649170B1 (en) * 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
EP1200466A2 (en) * 1999-07-13 2002-05-02 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family
US6537552B1 (en) * 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
US6776993B2 (en) * 2000-02-22 2004-08-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
WO2001062893A2 (en) * 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
WO2002015407A2 (en) 2000-08-11 2002-02-21 Koninklijke Philips Electronics N.V. Method and arrangement for synchronizing a σδ-modulator
EP1390755B1 (en) * 2001-01-08 2012-10-10 Isis Innovation Limited Assay to determine efficacy of treatment for mycobacterial infection
CA2451026C (en) * 2001-06-22 2013-12-10 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
FR2828934B1 (fr) * 2001-08-27 2004-08-13 Inst Nat Sante Rech Med Test de l'immunite cellulaire par des peptides fixes sur support solide
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
WO2005054851A1 (en) * 2003-11-21 2005-06-16 Institut Pasteur Recombinant adenylate cyclase of bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
ITRM20040091A1 (it) * 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
GB0406271D0 (en) * 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
US7820142B2 (en) * 2004-09-30 2010-10-26 Institut Pasteur Immunogenic glycopeptides, screening, preparation and uses
GB0500102D0 (en) * 2005-01-05 2005-02-09 Isis Innovation Method for generating a memory t cell response
US20080124738A1 (en) * 2005-03-01 2008-05-29 Pritest, Inc Compositions and methods of testing for tuberculosis and mycobacterium infection
US20080311159A1 (en) * 2005-03-31 2008-12-18 Michel Robert Klein Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease
EP1910410B1 (en) * 2005-07-01 2011-10-26 Forsyth Dental Infirmary for Children Tuberculosis antigen detection assays and vaccines
CA2616766A1 (en) * 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
GB0605474D0 (en) * 2006-03-17 2006-04-26 Isis Innovation Clinical correlates
EP2402024A1 (en) * 2006-06-28 2012-01-04 Statens Serum Institut Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
WO2008093354A1 (en) * 2007-01-31 2008-08-07 Council Of Scientific & Industrial Research A process for joining oxide superconducting tubes with a superconducting joint
GB0708874D0 (en) * 2007-05-08 2007-06-13 Univ The Of Birmingham Assay for detecting mycrobacterial infection
EP2185195A2 (en) * 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
EP2197908A2 (en) * 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
GB0722105D0 (en) * 2007-11-10 2007-12-19 Sec Dep For Environment Food A Antigens
US7670609B2 (en) * 2007-11-27 2010-03-02 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
ES2602430T3 (es) * 2008-07-25 2017-02-21 Glaxosmithkline Biologicals S.A. Polipéptidos, polinucleótidos y composiciones para uso en el tratamiento de tuberculosis latente
EP2385371B1 (en) * 2008-09-22 2014-10-22 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
US20100159485A1 (en) * 2008-12-19 2010-06-24 Centre For Dna Fingerprinting And Diagnostics Detection of mycobacterium tuberculosis
GB0906215D0 (en) * 2009-04-09 2009-05-20 Lalvani Ajit Diagnostic test
US8961989B2 (en) * 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis

Also Published As

Publication number Publication date
US8216795B2 (en) 2012-07-10
JP4633931B2 (ja) 2011-02-16
MXPA01004469A (es) 2002-08-30
US9005902B2 (en) 2015-04-14
CA2348475A1 (en) 2000-05-11
DK1144447T3 (da) 2010-02-08
US7632646B1 (en) 2009-12-15
EP1144447B1 (en) 2009-10-14
ATE445638T1 (de) 2009-10-15
US20130310271A1 (en) 2013-11-21
US7901898B2 (en) 2011-03-08
WO2000026248A3 (en) 2001-10-11
US20120264141A1 (en) 2012-10-18
ES2333073T3 (es) 2010-02-16
EP1144447A2 (en) 2001-10-17
WO2000026248A2 (en) 2000-05-11
DE69941545D1 (de) 2009-11-26
JP2002532064A (ja) 2002-10-02
US20100041075A1 (en) 2010-02-18
AU6480999A (en) 2000-05-22
BR9915055A (pt) 2001-08-07
US20110201044A1 (en) 2011-08-18
CN1350546A (zh) 2002-05-22
US8507211B2 (en) 2013-08-13

Similar Documents

Publication Publication Date Title
ID29858A (id) Uji diagnostik tuberkulosis
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ATE213068T1 (de) Testverfahren für peptidspezifische t-zellen
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
DE69421617T2 (de) Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen
NZ514887A (en) IBD-associated microbial antigens and methods of using same
AU7652194A (en) A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
WO1999009186A3 (fr) Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
JP2002532064A5 (id)
BR9506377A (pt) Peptídeo compreendendo uma subsequéncia de gp-39 hc proteina gp-39 hc ou peptideos composição farmacéutica uso da proteina gp-39 hc ou um ou mais dos peptídeos composição de diagnostico e processo de diagnóstico e kit de teste para a detecção de céçiças t auto-reativas ativadas
NZ301440A (en) Peptide p277 analogues; medicaments containing them; diagnostic kits
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DE60336138D1 (de) Verfahren zur diagnostik von tuberkulose
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
DE68927635D1 (de) Igm-antikörper gegen protamin
EP2071338A3 (en) Human diabetes-mediating proteins
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
FR2663034B1 (fr) Peptides de l'antigene sm-d et leur utilisation notamment pour le diagnostic du lupus erythemateux dissemine.
Meliconi et al. Antibodies to topoisomerase II in idiopathic pulmonary fibrosis
Kisilevsky et al. A comparison of accessibility of ribosomal proteins on free and membrane-bound ribosomes: the ribosomal proteins potentially involved in ribosome-membrane binding
Inoue et al. Enzymic lysis and structure of the cell walls of the oral Streptococcus mutans BHT
KR940000871A (ko) 한국형 c형 간염의 진단 방법 및 진단키트